Clinical application of methylation specific-polymerase chain reaction in serum of patients with gastric cancer

Hepato-Gastroenterology

Volumn 54, Issue 75, 2007, Pages 946-950

  Ikoma, Hisashi ^a   Ichikawa, Daisuke ^a   Ikoma, Daito ^a   Tani, Nobuyuki ^a   Koike, Hiroshi ^a   Okamoto, Kazuma ^a   Ochiai, Toshiya ^a   Ueda, Yuji ^a   Yamagishi, Hisakazu ^a   Otsuji, Eigo ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Gastric cancer; Hypermethylation; Methylation specific polymerase chain reaction; Serum; Tumor marker

Indexed keywords

PROTEIN P16; RETINOIC ACID RECEPTOR BETA; UVOMORULIN;

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER STAGING; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; FOLLOW UP; GASTRECTOMY; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; METHYLATION; POLYMERASE CHAIN REACTION; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROMOTER REGION; STOMACH CANCER;

AGED; DNA METHYLATION; DNA, NEOPLASM; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; POLYMERASE CHAIN REACTION; PROGNOSIS; PROMOTER REGIONS (GENETICS); RECEPTORS, RETINOIC ACID; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 34250214872     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Leon SA, Shapiro B, Sklaroff DM, et al: Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res 1977; 37:646-650.
2. Fournie GJ, Courtin JP, Laval F, et al: Plasma DNA as a marker of cancerous cell death. Investigations in patients suffering from lung cancer and in nude mice bearing human tumours. Cancer Lett 1995; 91:221-227.
3. Mulcahy H, Lyautey J, Lederrey C, et al: A prospective study of K-ras mutations in the plasma of pancreatic cancer patients. Clin Cancer Res 1998; 4:271-275.
4. Sorenson GD: Detection of mutated KRAS sequences as tumor markers in plasma/serum of patients with gastrointestinal cancer. Clin Cancer Res 2000; 6:2129-2137.
5. Herman JG, Graff JR, Myohanen S, et al: Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 1996; 93:9821-9826.
6. Sanchez-Cespedes M, Esteller M, Wu L, et al: Gene promoter hypermethylation in tumors and serum of head and neck cancer patients. Cancer Res 2000; 60:892-895.
7. Wong IH, Lo YM, Yeo W, et al: Frequent p15 promoter methylation in tumor and peripheral blood from hepatocellular carcinoma patients. Clin Cancer Res 2000; 6:3516-3521.
8. Hibi K, Taguchi M, Nakayama H, et al: Molecular detection of p16 promoter methylation in the serum of patients with esophageal squamous cell carcinoma. Clin Cancer Res 2001; 7:3135-3138.
9. Zou HZ, Yu BM, Wang ZW, et al: Detection of aberrant p16 methylation in the serum of colorectal cancer patients. Clin Cancer Res 2002; 8:188-191.
10. Lee TL, Leung WK, Chan MWY, et al: Detection of gene promoter hypermethylation in the tumor and serum of patients with gastric carcinoma. Clin Cancer Res 2002; 8:1761-1766.
11. Ichikawa D, Koike H, Ikoma H, et al: Detection of aberrant methylation as a tumor marker in serum of patients with gastric cancer. Anticancer Res 2004; 24:2477-2481.
12. Machado JC, Oliveira C, Carvalho R, et al: E-cadherin gene (CDH1) promoter methylation as the second hit in sporadic diffuse gastric carcinoma. Oncogene 2001; 20:1525-1528.
13. Oue N, Motoshita J, Yokozaki H, et al: Distinct promoter hypermethylation of p16INK4a, CDH1, and RAR-beta in intestinal, diffuse-adherent, and diffuse-scattered type gastric carcinomas. J Pathol 2002; 198:55-59.
14. Japanese Gastric Cancer Association: Japanese classification of gastric carcinoma: 2nd English Edition. Gastric Cancer 1998; 1:10-24.
15. Kuroki T, Trapasso F, Yendamuri S, et al: Allele loss and promoter hypermethylation of VHL, RAR-b, RASSF1A, and FHIT tumor suppressor genes on chromosome 3p in esophageal squamous cell carcinoma. Cancer Res 2003; 63:3724-3728.
16. Pisani PDM, Bray F, Ferlay J: Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer 1999; 83:18-29.
17. Maruyama K, Okabayashi K, Kinoshita Y: Prognosis in gastric cancer in Japan and its limits of radicality. World J Surg 1987; 11:418-425.
18. Maehara Y: S-1 in gastric cancer: a comprehensive review. Gastric Cancer 2003; 6:2-8.
19. Gerhard M, Juhl H, Kothoff H, et al: Specific detection of carcinoembryonic antigen-expressing tumor cells in bone marrow aspirates by polymerase chain reaction. J Clin Oncol 1994; 12:725-729.
20. Soeth E, Vogel I, Roder C, et al: Comparative analysis of bone marrow and venous blood isolates from gastrointestinal cancer patients for the detection of disseminated tumor cells using reverse transcription PCR. Cancer Res 1997; 57:3106-3110.
21. Raj GV, Mereno JG, Gomella LG: Utilization of polymerase chain reaction technology in the detection of solid tumor. Cancer 1998; 82:1419-1442.
22. Ichikawa D, Kitamura K, Tani N, et al: Molecular detection of disseminated cancer cells in the peripheral blood and expression of sialylated antigens in colon cancers. J Surg Oncol 2000; 75:98-102.
23. Nishida S, Kitamura K, Ichikawa D, et al: Molecular detection of disseminated cancer cells in the peripheral blood of patients with gastric cancer. Anticancer Res 2000; 20:2155-2159.
24. Koike H, Ichikawa D, Ikoma H, et al: Comparison of methylation-specific polymerase chain reaction with reverse transcriptase- polymerase chain reaction in peripheral blood of gastric cancer patients. J Surg Oncol 2004; 87:182-186.
25. Koike H, Ichikawa D, Ikoma H, et al: Comparison of serum aberrant methylation and conventional tumor markers in gastric cancer patients. Hepatogastroenterology 2005; 52:1293-1296.
26. Widschwendter A, Muller HM, Fiegl H, et al: DNA methylation in serum and tumor of cervical cancer patients. Clin Cancer Res 2004; 10:565-571.
27. Graziano F, Arduini F, Ruzzo A, et al: Prognostic analysis of E-cadherin gene promoter hypermethylation in patients with surgically resected, node-positive, diffuse gastric cancer. Clin Cancer Res 2004; 10:2784-2789.